• Skip to primary navigation
  • Skip to main content
  • Skip to footer
AKRN

AKRN

Scientific Consulting

  • Services
    • Clinical Services
    • Regulatory Services
    • Quality Management Services
    • Medical Writing
    • Clinical Data Management
    • Statistical Analysis and Reporting
    • Medical Aesthetic Devices
    • COVID-19
  • Team
    • Who we are
    • Our team
    • Code of Ethics
    • Our history
    • Our Community
  • News
    • News
    • Resources
    • Social Network
  • Career Portal
  • Contact
  • English
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter

ISO 20916 new international standard for IVDs

December 17, 2020 by AKRN

Good study practice for clinical evaluation of in-vitro diagnostic medical devices


The International Standard for clinical performance studies using specimens from human subjects was published in May 2019 (ISO 20916:2019). This is the first edition of a standard specifically focused on clinical performance studies for in-vitro diagnostic medical devices (IVDs).

 This standard provides requirements and guidance for manufacturers, clinicians, or researchers who execute clinical performance studies supporting regulatory requirements in the European Union (IVDR) for in-vitro diagnostic medical devices.

In-vitro diagnostic medical devices   

In vitro diagnostic (IVD) medical devices are used to conduct tests outside of the human body to provide valuable information regarding a person’s health or physiological status. IVDs include tests and related devices, such as test strips and reagents, using specimens such as blood, tissue, or urine, to carry out screening, diagnosis, prognosis, predictive testing, and monitoring conditions. 

IVD medical devices are fundamentally different from other medical devices because they perform their function outside of the body on specimens taken from the human body. Human subjects are typically not exposed to risks with IVD medical devices’ performance testing, except for the risk associated with specimen collection procedures or when the obtained information is used for patient management. These differences make the performance and risk characteristics of IVD medical devices different and unique from other medical devices.


The ISO 20916:2019 is specific for IVD medical devices 

The ISO 20916:2019 is specific for IVD medical devices and uses definitions and concepts appropriate for IVD medical devices. It is a stand-alone standard for clinical performance studies for IVD medical devices. In the situation for which there are an IVD medical device and a medical device used in an integrated system, both ISO 20916:2019 and ISO 14155:2020 might need to be considered. 

ISO 20916:2019 is the gold standard describing good study practice for the planning, design, conduct, recording, and reporting of clinical performance studies to assess the clinical performance and safety of in vitro diagnostic (IVD) medical devices for regulatory purposes.

This ISO standard identifies the principles that underpin clinical performance studies and specifies general requirements intended to:

  • ensure the conduct of the clinical performance study will lead to reliable and robust study results
  • define the responsibilities of the sponsor and principal investigator
  • assist sponsors, clinical research organization, investigators, ethics committees, regulatory authorities, and other bodies involved in the conformity assessment of IVD medical devices
  • protect the rights, safety, dignity, and well-being of the subjects providing specimens for use in clinical performance studies

The development process for in vitro diagnostic medical devices is complex. This, combined with a high degree of new IVDR requirements have made the IVDD to IVDR transition a complicated and time-consuming process for most device manufacturers.

Manufacturers of in vitro diagnostic medical devices should:

  • carefully study the requirements of the new IVDR
  • implement clinical evaluation procedures related to ISO 20916
  • perform an assessment of how their current product portfolio may be impacted by the new regulation
  • start clinical performance studies to ensure sufficient clinical evidence are available for their products

Analytical performance studies, and clinical performance studies performed for reasons other than pre-and post-market regulatory purposes, such as for reimbursement purposes, are out of the scope of the ISO 20916 standard.

Subject Matter Experts

Maria Nyåkern, Ph.D. Founder & Executive Director LinkedIn

Diana Posa, Pharm.D Associate Director Clinical Affairs LinkedIn

Share this article

Category iconCE Mark,  Clinical Trial,  European Union,  ISO 14155,  IVD,  IVDR,  Uncategorized Tag iconCE mark,  IVDR,  IVDs,  Medical Devices

Request a free consultation

Our team will help you to find the best solution for your needs. Our medical device experience and clinical knowledge can help you plan, set up, and execute a clinical trial, or performance study, in an optimal way.

Footer

AKRN Spain

AKRN Scientific Consulting S.L.
Address: Calle de Fuerteventura 4 (office 1.8)
Office Park La Marina
Postal Code: ES-28703 Madrid
Phone: +34 910 25 81 40
VAT ID: ES-B87990925

Contact details

Contact email: contact@akrnconsulting.com
Office phone: +34 910 258 140
Office phone: +34 911 136 635
Go to contact

Content

  • Medical Device Consulting Services
  • Clinical Studies for Medical Devices
  • Medical Writing
  • Regulatory Services
  • Contact

Resources

  • Articles
  • Resources
  • Career Portal

Latest articles

  • NEW AEMPS INSTRUCTION FOR MANUFACTURING LICENSE
  • DEVELOP AND IMPLEMENT YOUR QMS ACCORDING TO ISO 13485
  • Summary of Safety and Clinical Performance (SSCP/SSP)
  • Essential documents according to ISO 14155:2020
  • Roadmap to CE marking for medical devices and IVDs
  • The quality management system according to ISO 13485

AKRN Scientific Consulting S.L ha sido beneficiaria del Fondo Europeo de Desarrollo Regional cuyo objetivo es mejorar la competitividad de las Pymes y gracias al cual ha puesto en marcha un Plan de Marketing Digital Internacional con el objetivo de mejorar su posicionamiento online en mercados exteriores durante el año 2020. Para ello ha contado con el apoyo del Programa XPANDE DIGITAL de la Cámara de Comercio de Burgos.
“Una manera de hacer Europa”

AKRN Scientific Consulting S.L ha sido beneficiaria de la subvención de contratos de trabajo de la Comunidad de Madrid, cofinanciado por el Fondo Social Europeo y la Iniciativa de Empleo Juvenil, en el marco del Programa Operativo de Empleo Juvenil 2014-2020, gestionado por la Consejería de Economía, Empleo y Hacienda.

La empresa (AKRN Scientific Consulting S.L.) es beneficiaria del Programa “la Caixa” Empleo Joven de ayudas para el fomento de la contratación de personas jóvenes. Estas ayudas están cofinanciadas por el Programa Operativo de Empleo Juvenil / Iniciativa de Empleo Juvenil – Fondo Social Europeo y por la Fundación Bancaria “la Caixa”.

 

 

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter

Privacy policy – Cookie Policy – Legal Notice –  Copyright © 2022. All rights reserved. Return to top

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

Privacy Overview
AKRN

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!

Cookie Policy

More information about our Cookie Policy